إعلان
إعلان
LENZ
LENZ Therapeutics, Inc. Common Stock
14.87
USDبرعاية
-0.37
-2.43%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
14.95
+0.08
+0.54%
تقارير أرباح LENZ
النسبة الإيجابية المفاجئة
LENZ تفوق 9 من 18 آخر التقديرات.
50%
التقرير التالي
بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$2.00M
/-$0.99
التغير الضمني من Q3 25 (Revenue/ EPS)
-83.99%
/+67.80%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+115.22%
LENZ Therapeutics, Inc. Common Stock earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, LENZ reported earnings of -0.59 USD per share (EPS) for Q3 25, beating the estimate of -0.72 USD, resulting in a 18.10% surprise. Revenue reached 12.50 مليون, compared to an expected 6.96 مليون, with a 79.48% difference. The market reacted with a -23.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 المحللين forecast an EPS of -0.99 USD, with revenue projected to reach 2.00 مليون USD, implying an زيادة of 67.80% EPS, and نقصان of -83.99% in Revenue from the last quarter.
الأسئلة الشائعة
What were LENZ Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, LENZ Therapeutics, Inc. Common Stock reported EPS of -$0.59, beating estimates by 18.1%, and revenue of $12.50M, 79.48% above expectations.
How did the market react to LENZ Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -23.46%, changed from $28.05 before the earnings release to $21.47 the day after.
When is LENZ Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
What are the forecasts for LENZ Therapeutics, Inc. Common Stock's next earnings report?
Based on 8
المحللين, LENZ Therapeutics, Inc. Common Stock is expected to report EPS of -$0.99 and revenue of $2.00M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان